rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2008-6-24
|
pubmed:databankReference |
|
pubmed:abstractText |
The JELIS trial examined the preventive effect of eicosapentaenoic acid (EPA) against coronary artery diseases. Hypercholesterolemic patients received statin only (no EPA group: n=9319) or statin with EPA (EPA group: n=9326) for around 5 years. EPA significantly suppressed the incidence of coronary events in previous analysis. Herein, we investigated the effects of EPA on the primary and secondary prevention of stroke.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1524-4628
|
pubmed:author |
pubmed-author:HishidaHitoshiH,
pubmed-author:IshikawaYuichiY,
pubmed-author:ItakuraHiroshigeH,
pubmed-author:KitaToruT,
pubmed-author:KitabatakeAkiraA,
pubmed-author:LeónL MLM,
pubmed-author:MatsuzakiMasunoriM,
pubmed-author:MatsuzawaYujiY,
pubmed-author:NakayaNoriakiN,
pubmed-author:OikawaShinichiS,
pubmed-author:OrigasaHidekiH,
pubmed-author:SaitoYasushiY,
pubmed-author:SakataToshiieT,
pubmed-author:SasakiJunJ,
pubmed-author:ShimadaKazuyukiK,
pubmed-author:ShiratoKunioK,
pubmed-author:TanakaKortaroK,
pubmed-author:YokoyamaMitsuhiroM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2052-8
|
pubmed:dateRevised |
2009-11-5
|
pubmed:meshHeading |
pubmed-meshheading:18451347-Adult,
pubmed-meshheading:18451347-Aged,
pubmed-meshheading:18451347-Anticholesteremic Agents,
pubmed-meshheading:18451347-Eicosapentaenoic Acid,
pubmed-meshheading:18451347-Fatty Acids,
pubmed-meshheading:18451347-Female,
pubmed-meshheading:18451347-Humans,
pubmed-meshheading:18451347-Hypercholesterolemia,
pubmed-meshheading:18451347-Male,
pubmed-meshheading:18451347-Middle Aged,
pubmed-meshheading:18451347-Proportional Hazards Models,
pubmed-meshheading:18451347-Prospective Studies,
pubmed-meshheading:18451347-Recurrence,
pubmed-meshheading:18451347-Stroke
|
pubmed:year |
2008
|
pubmed:articleTitle |
Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial.
|
pubmed:affiliation |
Department of Neurology, Toyama University Hospital, 2630 Sugitani, Toyama, Toyama, 930-0194, Japan. kortaro@med.u-toyama.ac.jp
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|